<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.carenet.com/news/journal/carenet/63180</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-08</news:publication_date>
      <news:title>EGFR-TKI後のNSCLC、ivonescimabがOSを改善／JAMA</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63178</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-08</news:publication_date>
      <news:title>タモキシフェン治療中の乳がん患者のホットフラッシュ、ベンラファキシンが有望（HOFLA-V試験）／日本乳癌学会</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63162</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-08</news:publication_date>
      <news:title>日本人片頭痛患者に対する3年間の抗CGRP抗体継続治療、その有用性は</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63157</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-08</news:publication_date>
      <news:title>移植適応のある未治療多発性骨髄腫へのテクリスタマブベースの導入療法～第II相試験（MajesTEC-5）</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63146</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-08</news:publication_date>
      <news:title>死亡リスクが低下する適切な筋トレ時間は？</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/journal/carenet/63179</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-07</news:publication_date>
      <news:title>既治療の再発・難治性多発性骨髄腫、mezigdomide追加が有効／Lancet</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63161</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-07</news:publication_date>
      <news:title>トマトに認知機能改善効果は期待できるのか？</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63156</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-07-07</news:publication_date>
      <news:title>プラチナ抵抗性卵巣がんに対するrelacorilant＋nab-パクリタキセル、タキサン既治療例でも良好な結果（ROSELLA試験）／ASCO2026</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
</urlset>
